Home Search Contacts Help
ABPI - The Association of the British Pharmaceutical Industry
 
Target Diabetes

SOME QUESTIONS AND ANSWERS

What causes diabetes?

Type 1 diabetes is thought to be an autoimmune disease, in which the body's immune system attacks and destroys the beta cells in the pancreas that make insulin. It is not known exactly what triggers this immune attack, but susceptibility to the disease is inherited.

Type 1 diabetes usually appears in the first three decades of life and may develop quickly. It has evident symptoms and is life-threatening if not treated. The isolation of insulin by Banting and Best more than 80 years ago greatly improved the outlook for those with type 1 diabetes. Injecting insulin is still the main treatment for diabetes.

Type 2 diabetes typically emerges in middle or later life and has different causes from type 1. Growing resistance to the action of insulin, often related to the development of obesity, and an eventual failure of insulin-producing beta-cells in the pancreas underlie type 2 diabetes. At first, as blood glucose levels rise, the pancreas adjusts by increasing its output of insulin to compensate for this rise in glucose. Eventually, however, damage to the beta-cells causes a drop in insulin production and a further rise in blood glucose. For a long time, there may not be any clear symptoms, and it is thought that there may be a million or more people in the United Kingdom in whom the disease is present but not yet diagnosed. Because of this stealthy and silent onset, many people with type 2 diabetes already have detectable signs of one or more of the longer-term complications by the time the disease is diagnosed.

Susceptibility to type 2 diabetes is also known to be inherited, but this aspect is complex and little understood. A person's lifestyle has a major influence on whether or not they develop the disease, and how quickly. Making changes to these habits is a vital part of preventing and managing the disease. Type 2 diabetes is much more common than type 1 diabetes and accounts for about 90 per cent of all diagnosed cases of diabetes in the United Kingdom.

Gestational diabetes is said to be present when glucose intolerance, resulting from the development of insulin resistance, first emerges in pregnancy. This mainly occurs in the second or third trimester and affects about 2-5 per cent of pregnancies. Pregnancy affects blood glucose levels in many women (with the needs of the foetus tending to lower blood sugar levels), but in some mothers, blood sugar instead increases to the point where it is considered to indicate gestational diabetes.

Secretion of hormones from the placenta is a major cause of the insulin resistance. Following birth, when these hormone levels drop, blood glucose levels usually return to normal, but women who have experienced gestational diabetes have an approximately 30 per cent lifetime risk of subsequently developing type 2 diabetes.

Who gets diabetes?

In the United Kingdom, half of all people who eventually develop type 1 diabetes are diagnosed under the age of 15; 90 per cent have been diagnosed by the age of 30.

There is a large variation in the frequency of diagnosis of new cases per year between different countries. The figure is as high as 49 cases per 100,000 people per year in children up to the age of 14 in Finland and 32 per 100,000 per year in Sweden, through rates of 15 to 20 per 100,000 per year in the United Kingdom, to fewer than 5 per 100,000 people per year in many parts of South America and China. There may also be marked differences between different areas of the same country.

This suggests that both inherited and environmental factors may influence the onset of diabetes. Long term immigrants from a country with a low incidence rate who move to one with a high rate tend to show an increased incidence of the condition, approaching that in their adopted country.

Type 2 diabetes also varies in frequency from place to place. The highest rates are found in some US indigenous peoples (e.g. Pima Indians in Arizona) and in various South Pacific islands, but are generally low in low-income, rural communities, rising with development level and urbanisation. India and China are the countries with the largest number of diagnosed cases of type 2 diabetes.

In the United Kingdom, type 2 diabetes accounts for 85-90 per cent of all diagnosed cases of diabetes and prevalence increases markedly with age. Over the age of 35, prevalence is higher in men than in women. UK-based surveys have shown that the disease is more common in black Caribbean and especially South Asian (Indian, Pakistani, Bangladeshi) communities than in the white population.

Accurate statistics are not available for gestational diabetes, as there is no agreed standard definition. However, it is more likely to be seen in women who:

  • are obese
  • have a family history of type 2 diabetes
  • have had an unusually large baby in a previous pregnancy
  • had an unexplained stillbirth or neonatal death
  • belong to an ethnic group with an increased risk for type 2 diabetes.

 

 


 

 

 

 

 

 

 





Type 2 diabetes mostly develops from mid-life onwards.
Type 2 diabetes mostly develops from mid-life onwards.

- Click here for larger image

 

In the UK, there are significant variations in the frequency of type 2 diabetes between different population groups.
In the UK, there are significant variations in the frequency of type 2 diabetes between different population groups.

- Click here for larger image

< Previous Page | Contents | Next Page >
 
 
Previous Page | Print Page | Top of Page
Copyright © ABPI - The Association of the British Pharmaceutical Industry Terms and Conditions | Privacy Policy